Welcome to LookChem.com Sign In|Join Free
  • or
1-Piperidinecarboxylic acid, 4-[(4-hydroxyphenyl)methyl]-, 1,1-dimethylethyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

676528-97-5

Post Buying Request

676528-97-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

676528-97-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 676528-97-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,6,5,2 and 8 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 676528-97:
(8*6)+(7*7)+(6*6)+(5*5)+(4*2)+(3*8)+(2*9)+(1*7)=215
215 % 10 = 5
So 676528-97-5 is a valid CAS Registry Number.

676528-97-5Relevant academic research and scientific papers

Synthetic method of nitrogen-containing heterocyclic ring compound and intermediate of nitrogen-containing heterocyclic ring compound

-

Paragraph 0160-0165, (2022/03/27)

The invention relates to a nitrogen-containing heterocyclic ring compound and an intermediate synthesis method thereof. The synthesis method of the intermediate comprises the following step: carrying out photochemical reaction on a compound 1 and a compound 2 to prepare the intermediate. The synthesis method is mild in reaction condition, easy in reaction control and short in synthesis route, and has an industrial production prospect.

PYRAZOLOPYRIMIDIN-2-YL DERIVATIVES AS JAK INHIBITORS

-

Page/Page column 79; 80, (2015/06/25)

New pyrazolopyridmiin-2-yl derivatives are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Janus Kinases (JAK).

COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY

-

Page/Page column 51-52, (2009/11/29)

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of GPR119; such as, but not limited to, diabetes, obesity and associated metabolic disorders. Formula (I) is a compound, in which A can have up to 2 ring -CH2- group substituted with -C(O)- and can be partially unsaturated with up to 2 double bonds; Wi and W2 are independently selected from CR10 and N; wherein R10 is selected from hydrogen and C1_6alkyl; Yi is selected from NRn, O and S; wherein Rn is selected from hydrogen and C1_ 6alkyl; Y2 and Y3 are independently selected from CH and N; Y4 is selected from CH2, OCH2 and NR15; wherein R15 is selected from hydrogen and C1_6alkyl; or the pharmaceutically acceptable salts thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 676528-97-5